Leerink Partnrs Has Strong Forecast for Enhabit Q3 Earnings

Enhabit, Inc. (NYSE:EHAB) – Investment analysts at Leerink Partnrs increased their Q3 2026 earnings per share (EPS) estimates for Enhabit in a research report issued to clients and investors on Tuesday, November 18th. Leerink Partnrs analyst W. Mayo now anticipates that the company will earn $0.16 per share for the quarter, up from their prior estimate of $0.11. The consensus estimate for Enhabit’s current full-year earnings is $0.22 per share. Leerink Partnrs also issued estimates for Enhabit’s Q4 2026 earnings at $0.15 EPS, FY2026 earnings at $0.53 EPS and FY2029 earnings at $0.30 EPS.

Enhabit (NYSE:EHAB) last announced its earnings results on Wednesday, November 5th. The company reported $0.17 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.12 by $0.05. The firm had revenue of $263.60 million for the quarter, compared to analyst estimates of $267.08 million. Enhabit had a positive return on equity of 3.91% and a negative net margin of 1.14%. Enhabit has set its FY 2025 guidance at 0.500-0.560 EPS.

A number of other research analysts have also weighed in on the stock. UBS Group decreased their price target on shares of Enhabit from $10.00 to $8.50 and set a “neutral” rating on the stock in a research note on Friday, August 8th. Weiss Ratings reissued a “sell (e+)” rating on shares of Enhabit in a report on Wednesday. One research analyst has rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, Enhabit presently has a consensus rating of “Hold” and an average target price of $9.00.

Enhabit Stock Performance

EHAB opened at $8.51 on Friday. The firm’s fifty day simple moving average is $8.12 and its two-hundred day simple moving average is $8.40. Enhabit has a 52-week low of $6.47 and a 52-week high of $10.90. The company has a market cap of $430.41 million, a price-to-earnings ratio of -34.02 and a beta of 1.69. The company has a quick ratio of 1.58, a current ratio of 1.58 and a debt-to-equity ratio of 0.75.

Institutional Investors Weigh In On Enhabit

A number of large investors have recently made changes to their positions in the stock. Osaic Holdings Inc. lifted its position in Enhabit by 337.5% during the second quarter. Osaic Holdings Inc. now owns 2,616 shares of the company’s stock worth $25,000 after buying an additional 2,018 shares in the last quarter. State of Alaska Department of Revenue purchased a new position in shares of Enhabit during the 3rd quarter worth $27,000. Tower Research Capital LLC TRC boosted its position in shares of Enhabit by 82.9% during the 2nd quarter. Tower Research Capital LLC TRC now owns 4,542 shares of the company’s stock valued at $44,000 after acquiring an additional 2,059 shares during the last quarter. Russell Investments Group Ltd. boosted its position in shares of Enhabit by 523.1% during the 2nd quarter. Russell Investments Group Ltd. now owns 5,795 shares of the company’s stock valued at $56,000 after acquiring an additional 4,865 shares during the last quarter. Finally, Jones Financial Companies Lllp grew its stake in shares of Enhabit by 110,987.5% in the 1st quarter. Jones Financial Companies Lllp now owns 8,887 shares of the company’s stock valued at $78,000 after buying an additional 8,879 shares during the period.

About Enhabit

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.